시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
유도만능줄기세포 생산 시장 규모, 점유율, 성장 분석 : 프로세스별, 워크플로우별, 제품별, 용도별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)
Induced Pluripotent Stem Cells Production Market Size, Share, and Growth Analysis, By Process (Manual, Automated), By Workflow (Reprogramming, Cell Culture), By Product, By Application, By End-Use, By Region - Industry Forecast 2025-2032
상품코드 : 1687538
리서치사 : SkyQuest
발행일 : 2025년 03월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,652,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,951,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,250,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

유도만능줄기세포 생산 시장 규모는 2023년에 15억 3,000만 달러로, 2024년 16억 8,000만 달러에서 2032년에는 34억 9,000만 달러로 확대하며, 예측 기간(2025-2032년)의 CAGR은 9.6%로 성장할 전망입니다.

줄기세포(iPSC) 제조 시장은 재생의료 및 세포치료 분야에서 괄목할 만한 성장과 혁신을 이루고 있습니다. 성체 세포에서 유도되어 다능성 상태로 재프로그래밍된 iPSC는 개인 맞춤형 치료와 질병 모델링에 큰 잠재력을 제공합니다. 이 급성장하는 시장은 신약개발과 다양한 질환에 대한 iPSC의 적용에 대한 이해도가 높아짐에 따라 성장하고 있습니다. R&D 및 생명공학 기업은 확장 가능하고 비용 효율적인 iPSC 생산을 위한 효율적인 기술을 적극적으로 개발하고 있습니다. 학계, 산업계, 의료기관의 협업이 진보를 촉진하는 한편, 엄격한 규제 프레임워크와 윤리적 고려사항은 표준화된 방법론의 필요성을 강조하는 환경을 조성하고 있습니다. 세계 헬스케어의 발전과 함께 iPS 세포 제조 시장은 지속적으로 확대될 것이며, 과학적 혁신과 치료 솔루션의 길을 열어줄 것입니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

유도만능줄기세포 생산 시장 규모 : 프로세스별 & CAGR(2025-2032)

유도만능줄기세포 생산 시장 규모 : 워크플로우별 & CAGR(2025-2032)

유도만능줄기세포 생산 시장 규모 : 제품별 & CAGR(2025-2032)

유도만능줄기세포 생산 시장 규모 : 용도별 & CAGR(2025-2032)

유도만능줄기세포 생산 시장 규모 : 최종 용도별 & CAGR(2025-2032)

유도만능줄기세포 생산 시장 규모 : 지역별 & CAGR(2025-2032)

경쟁 정보

주요 기업 개요

결론과 제안

KSA
영문 목차

영문목차

Induced Pluripotent Stem Cells Production Market size was valued at USD 1.53 billion in 2023 and is poised to grow from USD 1.68 billion in 2024 to USD 3.49 billion by 2032, growing at a CAGR of 9.6% during the forecast period (2025-2032).

The triggered pluripotent stem cell (iPSC) manufacturing market is experiencing remarkable growth and innovation within regenerative medicine and cellular therapy. Derived from adult cells and reprogrammed into a pluripotent state, iPSCs offer significant potential for personalized treatments and disease modeling. This burgeoning market is fueled by an increasing understanding of iPSCs' applications in drug discovery and various medical conditions. Researchers and biotech firms are actively developing efficient techniques for scalable and cost-effective iPSC production. Collaborations among academia, industry, and healthcare institutions are driving advancements, while stringent regulatory frameworks and ethical considerations shape the landscape, highlighting the need for standardized practices. As global healthcare evolves, the iPSC manufacturing market is set for continued expansion, paving the way for scientific breakthroughs and therapeutic solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Induced Pluripotent Stem Cells Production market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Induced Pluripotent Stem Cells Production Market Segments Analysis

Global Induced Pluripotent Stem Cells Production Market is segmented by Process, Workflow, Product, Application, End-Use and region. Based on Process, the market is segmented into Manual and Automated. Based on Workflow, the market is segmented into Reprogramming and Cell Culture. Based on Product, the market is segmented into Consumables & Kits, Instruments and Services. Based on Application, the market is segmented into Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, Disease Modeling and Others. Based on End-Use, the market is segmented into Academic & Research Institutes, Biotechnology & Pharmaceutical Companies and Hospitals & Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Induced Pluripotent Stem Cells Production Market

A significant driving force behind the global induced pluripotent stem cells (iPSC) production market is the ongoing advancements in regenerative medicine. These stem cells present substantial potential for creating personalized and effective treatments for various medical conditions, thereby attracting significant investment in research and development. Such innovations not only broaden the applications of iPSCs but also present novel therapeutic options, which significantly propel market growth. The increasing interest from pharmaceutical companies and healthcare institutions further enhances this trend, underscoring the pivotal role that advancements in regenerative medicine play in fostering market expansion and stimulating continued investment in iPSC technologies.

Restraints in the Induced Pluripotent Stem Cells Production Market

One significant constraint facing the global induced pluripotent stem cells (iPSC) production market is the array of ethical and regulatory hurdles. Issues regarding the use of human-derived materials, coupled with concerns about the potential misuse of iPSC technology, have led to the implementation of strict regulations in various regions. These obstacles can impede research initiatives, raise compliance costs, and generate market uncertainty. Consequently, such factors can hinder the pace of iPSC adoption and commercialization, ultimately affecting the growth and development of this promising sector in regenerative medicine and biotechnology.

Market Trends of the Induced Pluripotent Stem Cells Production Market

The global Induced Pluripotent Stem Cells (iPSC) production market is witnessing a significant trend driven by the emergence of iPSC-based disease modeling. Researchers and pharmaceutical companies are increasingly leveraging iPSC technology to develop disease-specific cell lines, facilitating more accurate and personalized modeling of a variety of diseases, including genetic disorders, neurodegenerative conditions, and cardiovascular diseases. This shift not only enhances drug discovery and development processes but also fosters the emergence of targeted and effective therapeutic strategies, ultimately shaping the future landscape of precision medicine. As a result, the demand for iPSC products is expected to surge, propelling market growth in the coming years.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Induced Pluripotent Stem Cells Production Market Size by Process & CAGR (2025-2032)

Global Induced Pluripotent Stem Cells Production Market Size by Workflow & CAGR (2025-2032)

Global Induced Pluripotent Stem Cells Production Market Size by Product & CAGR (2025-2032)

Global Induced Pluripotent Stem Cells Production Market Size by Application & CAGR (2025-2032)

Global Induced Pluripotent Stem Cells Production Market Size by End-Use & CAGR (2025-2032)

Global Induced Pluripotent Stem Cells Production Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기